SOURCES SOUGHT
66 -- CO2 Incubators
- Notice Date
- 6/13/2014
- Notice Type
- Sources Sought
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 3900 NCTR Road, HFT-320, Bldg 50 | Rm 421, Jefferson, Arkansas, 72079, United States
- ZIP Code
- 72079
- Solicitation Number
- 1134433
- Archive Date
- 7/9/2014
- Point of Contact
- Crystal G. McCoskey, Phone: 8705437267
- E-Mail Address
-
crystal.mccoskey@fda.hhs.gov
(crystal.mccoskey@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- MARKET RESEARCH PURPOSES ONLY NOT A REQUEST FOR PROPOSAL OR SOLICITATION The U.S. Food and Drug Administration (FDA), is conducting market research to support the Center for Biologics Evaluation and Research's (CBER) requirement for eight (8) tissue culture incubators to include inside delivery, set-up and on-site operator training/familiarization. This is a sources sought to determine the availability and capability of small business manufacturers or small businesses capable of supplying a U.S. made product of a small business manufacturer or producer. The associated North American Industry Classification System (NAICS) Code is‐ 334516 ‐ Analytical Laboratory Instrument Manufacturing; Small Business Size Standard is 500 employees. REQUIREMENTS: Part I: General Information A. Introduction The U.S. Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER) has a requirement for eight (8) tissue culture incubators for use in a Bio-Safety Level 3 (BSL3) laboratory to include inside delivery, set-up and on-site operator training/familiarization. B. Background CBER conducts work with highly pathogenic influenza viruses in its BSL3 laboratories. Influenza viruses will be cultured in eggs and mammalian cells using the incubators. The incubators shall be suitable to house eggs and tissue culture flasks under varying temperatures, high levels of humidity, and different percentages of CO2 (range from 0 - 10%). Part II: Work Requirements A. Technical Requirements The tissue culture incubators shall have a minimum of the following salient characteristics: 1. Shall be stackable (2 per stack). 2. Shall have C02 sensor with ability to control percent CO2 in the chamber. 3. Shall be air jacketed. 4. Doors shall be hinged on left. 5. Shall use 115V power source. 6. Shall have full sterilization cycle to eliminate all contaminants. 7. Shall have humidity display and control. 8. Shall have a HEPA filtration system external to the chamber. 9. Interior shall be 5.0 cubic foot. 10. Shall have a crevice free interior. 11. Shall have at least four (4) polished shelves. 12. Shall include a water pan that provides maximum surface area for water to evaporate. 13. Shall include a monitor that allows remote monitoring of CO2 levels and incubator temperature. 14. Shall include leg levelers/castors. 15. Shall include an external CO2 tank switch. 16. Shall include a minimum of a 24 month parts and labor warranty. B. Installation and Training: The Contractor shall provide inside delivery and setup of the incubators at the address provided below, to include shipping. Upon setup of the incubators, the contractor shall provide on-site operator training/familiarization for up to four (4) attendees. Part III: Supporting Information A. Security Contractor shall deliver to the loading dock of building 52/72 on the White Oak campus where they will meet with the end-user who will show them where (in which building on campus) the incubators need to be installed. This will require security screening into the building. B. Ship to: Food and Drug Administration Division of Viral Products OVRR/CBER 10903 New Hampshire Avenue Building 52/72 loading dock (installation building to be determined upon arrival) Silver Spring, MD 20993-0002 Delivery shall be coordinated with the Project Officer (to be provided at award). C. Period of Performance Inside delivery, set-up and on-site operator training/familiarization shall occur within 60 calendar days from date of award. Responses to this sources sought shall unequivocally demonstrate that respondent is regularly engaged in the manufacture and/or sale of same or substantially similar items. Though the target audience is small business manufacturers or small businesses capable of supplying a U.S. made product of a small business manufacturer or producer all interested parties may respond. At a minimum, responses shall include the following: • Business name and bio, DUNS number, business address, business website, business size status (i.e., SB, VOSB, SDVOSB, HUBZone SB, 8(a), SDB, WOSB, EDWOSB, LB), point of contact name, mailing address (if different from business address), phone number and email address; [Provide this same information again for the manufacturer/producer if responding to provide a product manufactured by another firm.] • Three (3) years of past performance information for the manufacture and/or sale of same or substantially similar items, which are or have been used with same or similar equipment for same or similar purposes, to include date of sale, description (should also include technical literature and specifications), dollar value, client name, client address, client point of contact name, client point of contact mailing address (if different from that provided for client), client point of contact phone number, client point of contact email address, and name of the manufacturer (to include DUNS number and size status) if respondent is not the manufacturer/producer; • Descriptive literature, brochures, specifications, marketing material, etc. detailing the nature of the items the responding firm is regularly engaged in manufacturing and/or selling; • If applicable, identification of the firm's GSA Schedule contract(s) by Schedule number and SINs that are applicable to this requirement; • If a large business, identify any existing subcontracting opportunities for small business concerns; • Although this is not a request for quote, informational pricing is encouraged; • The Government encourages any comments and/or suggestions from any interested party, regarding the specifications. While the Government will not respond directly to your comments and/or suggestions; we will consider them as we finalize the specifications in preparation for the forthcoming solicitation. The Government is not responsible for locating or securing any information, not identified in the response. Interested Parties must respond with capability statements which are due in person, by postal mail or email to the point of contact listed below on or before June 24, 2014 by 1:00 PM (Central Time in Jefferson, Arkansas) at the Food and Drug Administration, OC/OA/OAGS, Attn: Crystal G. McCoskey, 3900 NCTR Road, Bldg 50/Room 426, HFT‐320, Jefferson, AR 72079‐9502, or email crystal.mccoskey@fda.hhs.gov. Reference #1134433 in all correspondence with the point of contact listed above. Notice of Intent Responses to this sources sought announcement will assist the Government in determining whether this requirement should be set aside for small business, made available to full and open competition or procured through other than full and open acquisition procedures. Disclaimer and Important Notes This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a combined synopsis/solicitation (No. 1134433) may be published via FedBizOpps. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/NCTR/1134433/listing.html)
- Place of Performance
- Address: Food and Drug Administration, Division of Viral Products, OVRR/CBER, 10903 New Hampshire Avenue, Building 52/72 loading dock (installation building to be determined upon arrival), Silver Spring, Maryland, 20993, United States
- Zip Code: 20993
- Zip Code: 20993
- Record
- SN03395148-W 20140615/140613234934-6e3b42fbe61266d4a0800853be57b153 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |